wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44778300-9EE1B87A-8B03-459E-BB1B-2009C07865D4
Q44778300-9EE1B87A-8B03-459E-BB1B-2009C07865D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-9EE1B87A-8B03-459E-BB1B-2009C07865D4
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.
P2860
Q44778300-9EE1B87A-8B03-459E-BB1B-2009C07865D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-9EE1B87A-8B03-459E-BB1B-2009C07865D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da93738df30da014798f15936346ab13b32d57f0
P2860
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I